Nutritional neuroscience · 2026
Effect of anti-inflammatory diets based on complementary and alternative medicine in multiple sclerosis: a systematic review and meta-analysis of clinical trials.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Moravejolahkami Amir Reza, Nazari Vida, Zare Hossein Abadi Fatemeh, Mohammadnezhad Masoud
Аннотация
BACKGROUND: The role of diet in modulating inflammation has garnered attention, particularly regarding anti-inflammatory dietary interventions rooted in complementary medicine. The present study examined the clinical manifestations through which anti-inflammatory diets may influence MS, providing insights for clinician researchers.
METHODS: A thorough search was performed in Scopus, MEDLINE (PubMed), ScienceDirect, EMBASE, Google Scholar, Central Cochrane Library, and the Web of Science, covering trials published until December 2025. Random-effects models were used to analyze the quantitative data through STATA14.
RESULTS: After analyzing 246 entries, we found 10 Randomized Controlled Trials (RCTs) with a total of 332 participants, who had an average disease duration of 8.7 years. The combined effect size revealed a decrease in fatigue severity (Weighted Mean Difference [WMD] = -7.10; 95% Confidence Interval [CI] = -13.61, -0.59; P = 0.032) and an increase in physical health score (WMD = 2.59; 95% Confidence Interval [CI] = 0.17, 5.00; P = 0.036).
CONCLUSION: Anti-inflammatory diets may improve MS clinical manifestations, especially fatigue and disability; therefore, more research is needed to confirm the present findings.
METHODS: A thorough search was performed in Scopus, MEDLINE (PubMed), ScienceDirect, EMBASE, Google Scholar, Central Cochrane Library, and the Web of Science, covering trials published until December 2025. Random-effects models were used to analyze the quantitative data through STATA14.
RESULTS: After analyzing 246 entries, we found 10 Randomized Controlled Trials (RCTs) with a total of 332 participants, who had an average disease duration of 8.7 years. The combined effect size revealed a decrease in fatigue severity (Weighted Mean Difference [WMD] = -7.10; 95% Confidence Interval [CI] = -13.61, -0.59; P = 0.032) and an increase in physical health score (WMD = 2.59; 95% Confidence Interval [CI] = 0.17, 5.00; P = 0.036).
CONCLUSION: Anti-inflammatory diets may improve MS clinical manifestations, especially fatigue and disability; therefore, more research is needed to confirm the present findings.